Slate Path Capital
Overview
Slate Path Capital is a global long/short equity hedge fund manager that aims for long-term, risk-adjusted capital growth using a fundamental, research-based security selection process.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tvardi | Jun 2021 | Series B | Lead |
| City Therapeutics | Jun 2026 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Slate Path Capital based?
Slate Path Capital is headquartered in New York City, New York, United States.
When was Slate Path Capital founded?
Slate Path Capital was founded in 2012.
How many portfolio companies does Slate Path Capital have?
Slate Path Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Slate Path Capital's portfolio?
Portfolio companies visible on Caplight include Tvardi, City Therapeutics.
What was Slate Path Capital's most recent investment shown here?
Slate Path Capital's most recent investment in this portfolio sample was in City Therapeutics in 2026.
What sectors does Slate Path Capital focus on?
Slate Path Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Slate Path Capital focus on?
Slate Path Capital typically invests at the Mid stage.
What is Slate Path Capital's AUM?
Slate Path Capital's assets under management are estimated between $5.0B and $8.4B.